167 related articles for article (PubMed ID: 30633201)
1. Tenascin-C expression is significantly associated with the progression and prognosis in gastric GISTs.
Shen C; Wang C; Yin Y; Chen H; Yin X; Cai Z; Chen Z; Zhang B; Zhou Z
Medicine (Baltimore); 2019 Jan; 98(2):e14045. PubMed ID: 30633201
[TBL] [Abstract][Full Text] [Related]
2. The role of Tenascin-C and Twist1 in gastric cancer: cancer progression and prognosis.
Qi W; Yang Z; Li H; Cui Y; Xuan Y
APMIS; 2019 Feb; 127(2):64-71. PubMed ID: 30698309
[TBL] [Abstract][Full Text] [Related]
3. High Co-expression of Large Tenascin C Splice Variants in Stromal Tissue and Annexin A2 in Cancer Cell Membranes is Associated with Poor Prognosis in Pancreatic Cancer.
Hagiwara K; Harimoto N; Yokobori T; Muranushi R; Hoshino K; Gantumur D; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Tanaka H; Watanabe A; Kubo N; Araki K; Hosouchi Y; Shirabe K
Ann Surg Oncol; 2020 Mar; 27(3):924-930. PubMed ID: 31463696
[TBL] [Abstract][Full Text] [Related]
4. Tenascin-C is a potential cancer-associated fibroblasts marker and predicts poor prognosis in prostate cancer.
Ni WD; Yang ZT; Cui CA; Cui Y; Fang LY; Xuan YH
Biochem Biophys Res Commun; 2017 May; 486(3):607-612. PubMed ID: 28341124
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological features, surgical strategy and prognosis of duodenal gastrointestinal stromal tumors: a series of 300 patients.
Liu Z; Zheng G; Liu J; Liu S; Xu G; Wang Q; Guo M; Lian X; Zhang H; Feng F
BMC Cancer; 2018 May; 18(1):563. PubMed ID: 29764388
[TBL] [Abstract][Full Text] [Related]
6. Surgical resection should be taken into consideration for the treatment of small gastric gastrointestinal stromal tumors.
Yang J; Feng F; Li M; Sun L; Hong L; Cai L; Wang W; Xu G; Zhang H
World J Surg Oncol; 2013 Oct; 11():273. PubMed ID: 24119564
[TBL] [Abstract][Full Text] [Related]
7. Clinical and prognostic significance of Raf kinase inhibitory protein expression in gastrointestinal stromal tumors.
Wang Y; Chen JJ; Wang XF; Wang Q
World J Gastroenterol; 2018 Jun; 24(23):2508-2517. PubMed ID: 29930472
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological characteristics and prognosis of primary appendiceal stromal tumors.
Zhang B; Zheng GL; Zhu HT; Zhao Y; Zheng ZC
World J Surg Oncol; 2018 Nov; 16(1):225. PubMed ID: 30445975
[TBL] [Abstract][Full Text] [Related]
9. Expression profiling of GIST: CD133 is associated with KIT exon 11 mutations, gastric location and poor prognosis.
Arne G; Kristiansson E; Nerman O; Kindblom LG; Ahlman H; Nilsson B; Nilsson O
Int J Cancer; 2011 Sep; 129(5):1149-61. PubMed ID: 21064103
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumors presenting as omental masses--a clinicopathologic analysis of 95 cases.
Miettinen M; Sobin LH; Lasota J
Am J Surg Pathol; 2009 Sep; 33(9):1267-75. PubMed ID: 19440146
[TBL] [Abstract][Full Text] [Related]
11. Expression of alpha6 integrin subunit is associated with malignancy in gastric gastrointestinal stromal tumors.
Takeyama H; Funahashi H; Sawai H; Takahashi H; Yamamotorm M; Akamo Y; Manabe T
Med Sci Monit; 2007 Feb; 13(2):CR51-6. PubMed ID: 17261983
[TBL] [Abstract][Full Text] [Related]
12. [Clinical analysis of 63 cases with gastric gastrointestinal stromal tumors].
Rong L; Wan YL; Nian WD; Liu P; Liang JY
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jan; 12(1):24-7. PubMed ID: 19145498
[TBL] [Abstract][Full Text] [Related]
13. Two staging systems for gastrointestinal stromal tumors in the stomach: which is better?
Park CH; Kim GH; Lee BE; Song GA; Park DY; Choi KU; Kim DH; Jeon TY
BMC Gastroenterol; 2017 Dec; 17(1):141. PubMed ID: 29207963
[TBL] [Abstract][Full Text] [Related]
14. S100A4 expression is associated with poor prognosis in patients with resectable gastrointestinal stromal tumor.
Shen W; Tan X; Hao F
Libyan J Med; 2019 Dec; 14(1):1659669. PubMed ID: 31474194
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Factors of Patients with Gastric Gastrointestinal Stromal Tumor after Curative Resection: A Retrospective Analysis of 406 Consecutive Cases in a Multicenter Study.
Kim IH; Kwak SG; Chae HD
Eur Surg Res; 2015; 55(1-2):12-23. PubMed ID: 25766570
[TBL] [Abstract][Full Text] [Related]
16. Expression of EGFR in gastric stromal tumors: a clinicopathologic study.
Qiu X; Montgomery E
Appl Immunohistochem Mol Morphol; 2008 Jul; 16(4):310-5. PubMed ID: 18528288
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of ING4 expression on gastric gastrointestinal stromal tumors by immunohistochemistry.
Sahin S; Ekinci O; Seckin S; Dursun A
Ann Ital Chir; 2017; 88():311-317. PubMed ID: 28566557
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological features and prognosis of mesenteric gastrointestinal stromal tumor: evaluation of a pooled case series.
Feng F; Feng B; Liu S; Liu Z; Xu G; Guo M; Lian X; Fan D; Zhang H
Oncotarget; 2017 Jul; 8(28):46514-46522. PubMed ID: 28147326
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of PTEN, Ki-67 and CD44s expression patterns in gastrointestinal stromal tumors.
Liang YM; Li XH; Li WM; Lu YY
World J Gastroenterol; 2012 Apr; 18(14):1664-71. PubMed ID: 22529697
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of gastrointestinal stromal tumors of the stomach: report of 28 cases.
Wu Y; Zhu X; Ding Y
Ann Clin Lab Sci; 2007; 37(1):15-21. PubMed ID: 17311865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]